Mark Laurence Boys

USPTO Granted Patents = 25 (Patent Applications = 8)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 8.7

ph-index = 3

Forward Citations = 34(Granted Patents)

Location History:

Mt. Prospect, IL (US) (2003)
Mount Prospect, IL (US) (2005 - 2006)
Brighton, MI (US) (2006 - 2010)
Lyons, FR (2015)
Boulder, CO (US) (2014 - 2023)
Lyons, CO (US) (2011 - 2024)

Company Filing History:

Pharmacia Corporation

Thesan Pharmaceuticals, Inc.

patents

6. 1 out of 66

Medicis Pharmaceutical Corporation

patents

7. 1 out of 7

Graceway Pharmaceuticals, LLC

patents

8. 1 out of 1

Fbm Therapeutics, LLC

patent

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187721 - Protein tyrosine phosphatase inhibitors (2025-01-07),

2. 11884664 - Protein tyrosine phosphatase inhibitors (2024-01-30),

3. 11834453 - Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors (2023-12-05),

4. 11802127 - 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors (2023-10-31),

5. 11691973 - 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors (2023-07-04),

6. 11634417 - Protein tyrosine phosphatase inhibitors (2023-04-25),

7. 11247990 - Bicyclic fused pyridine compounds as inhibitors of TAM kinases (2022-02-15),

8. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors (2021-06-08),

9. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors (2020-08-04),

10. 10669269 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors (2020-06-02),

11. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors (2019-01-29),

12. 9938289 - Therapeutic pyrazolyl thienopyridines (2018-04-10),

13. 9809590 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors (2017-11-07),

14. 9260450 - Therapeutic pyrazolyl thienopyridines (2016-02-16),

15. 9174981 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors (2015-11-03),

Title: Inventor Spotlight: Mark Laurence Boys

Introduction:

Mark Laurence Boys is a prolific inventor based in Boulder, CO (US), with an impressive portfolio of 11 patents to his name. His groundbreaking work in the field of pharmaceuticals and hyperproliferative diseases has made a significant impact on the medical industry.

Latest Patents:

1. Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors: Mark's invention focuses on compounds with Formula (I) and their pharmaceutically acceptable salts, showing promising results in the treatment of abnormal cell growth, particularly in cancer patients.

2. Protein tyrosine phosphatase inhibitors: His work on compounds of Formula I has shown potential for treating hyperproliferative diseases and associated pathological conditions, offering new avenues for diagnosis and treatment in mammalian cells.

Career Highlights:

Mark has made substantial contributions to the field through his tenure at companies like Array Biopharma Inc. and Celgene Corporation. His innovative spirit and dedication to research have been instrumental in developing novel pharmaceutical solutions that benefit patients worldwide.

Collaborations:

Throughout his career, Mark has collaborated with esteemed professionals like Erik James Hicken and Ellen Ruth Laird. Together, they have worked towards pushing the boundaries of medical science and developing cutting-edge treatments for complex diseases.

Conclusion:

In conclusion, Mark Laurence Boys stands out as a pioneering inventor in the realm of pharmaceuticals and disease treatment. His patents and collaborations reflect a deep commitment to advancing medical research and improving outcomes for patients. Mark's innovative spirit continues to drive advancements in the field, making him a revered figure in the world of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.